RISEDRONATE SODIUM Recall D-0762-2022
Description: Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.
RISEDRONATE SODIUM Recall D-0762-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0762-2022 |
Event ID | 89766 |
Brand | RISEDRONATE SODIUM |
Generic Name | RISEDRONATE SODIUM |
Manufacturer | RISEDRONATE SODIUM |
Original Package? | 1 |
Active Substance | RISEDRONATE SODIUM |
Drug Route | ORAL |
Distribution | USA Nationwide |
Quantity | 4872 bottles |
Recall Reason | FAILED CONTENT UNIFORMITY SPECIFICATIONS |
Drug Classification | Class III |
Drug Code Info | 20220413 |
Product NDC | 33342-107 33342-108 33342-109 |
Recall Initiation Date | 20220310 |
Report Date | 20220413 |
Classification Date | 20220407 |
Address | 666 Plainsboro Rd Bldg 200 Ste 230 Plainsboro, NJ 08536-0009 United States |
Recalling Firm | Macleods Pharma Usa Inc |
Initial Notification | Letter |
Unique Ingredient Identifier | OFG5EXG60L |
Drug Application Number | ANDA203533 |
Structured Product Labeling (SPL ID) | 4607af24-13bd-474e-8488-1a73488af3e2 |
Structured Product Labeling (SPL Set ID) | 62aff8d6-a2f7-4c7e-a102-c70105ac3792 |
Similar To |